Skip Nav Destination
Article|
May 1, 1973
Ristocetin: A Means of Differentiating Von Willebrand’s Disease Into Two Groups
Margaret A. Howard, M.Sc.,
Margaret A. Howard, M.Sc.
Professional Officer
1Monash University Department of Medicine, and the Department of Hematology, Alfred Hospital, Melbourne, Victoria, Australia.
2Monash University Department of Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Search for other works by this author on:
R. J. Sawers, M.B., B.S., MC. Path.,
R. J. Sawers, M.B., B.S., MC. Path.
Director
1Monash University Department of Medicine, and the Department of Hematology, Alfred Hospital, Melbourne, Victoria, Australia.
3Department of Hematology, Alfred Hospital, Melbourne, Victoria, Australia.
Search for other works by this author on:
B. G. Firkin, MB., B.S., F.R.A.C.P.
B. G. Firkin, MB., B.S., F.R.A.C.P.
Professor of Medicine
1Monash University Department of Medicine, and the Department of Hematology, Alfred Hospital, Melbourne, Victoria, Australia.
2Monash University Department of Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Search for other works by this author on:
Blood (1973) 41 (5): 687–690.
Article history
Submitted:
February 18, 1972
Revision Received:
October 10, 1972
Accepted:
October 11, 1972
Citation
Margaret A. Howard, R. J. Sawers, B. G. Firkin; Ristocetin: A Means of Differentiating Von Willebrand’s Disease Into Two Groups. Blood 1973; 41 (5): 687–690. doi: https://doi.org/10.1182/blood.V41.5.687.687
Download citation file:
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal